The application of genetics to inherited bleeding disorders

Haemophilia

Volumn 16, Issue SUPPL. 5, 2010, Pages 35-39

  James, P ^a   Di Paola, J ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b University of Colorado Denver and Children s Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

ARTICLE; DISEASE CARRIER; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HEMOPHILIA; HUMAN; MUTATIONAL ANALYSIS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VON WILLEBRAND DISEASE;

BLOOD COAGULATION DISORDERS, INHERITED; BLOOD COAGULATION FACTORS; GENETIC TESTING; GENOME; HEMOPHILIA A; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 77955033931     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02291.x     Document Type: Article

References (28)

1. Mannucci PM, Tuddenham EG. The hemophilias - from royal genes to gene therapy. N Engl J Med 2001, 344:1773-9.
2. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987, 69:454-9.
3. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993, 123:893-8.
4. Ginsburg D, Handin RI, Bonthron DT. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 1985, 228:1401-3.
5. Mancuso DJ, Tuley EA, Westfield LA. Structure of the gene for human von Willebrand factor. J Biol Chem 1989, 264:19514-27.
6. Mancuso DJ, Tuley EA, Westfield LA. Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry 1991, 30:253-69.
7. Sadler JE, Budde U, Eikenboom JC. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006, 4:2103-14.
8. Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med 1980, 302:1047-51.
9. Cooney KA, Lyons SE, Ginsburg D. Functional analysis of a type IIB von Willebrand disease missense mutation: increased binding of large von Willebrand factor multimers to platelets. Proc Natl Acad Sci USA 1992, 89:2869-72.
10. Hillery CA, Mancuso DJ, Evan SJ. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets. Blood 1998, 91:1572-81.
11. Mazurier C. von Willebrand disease masquerading as haemophilia A. Thromb Haemost 1992, 67:391-6.
12. Nesbitt IM, Goodeve AC, Guilliatt AM, Makris M, Preston FE, Peake IR. Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques. Thromb Haemost 1996, 75:959-64.
13. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996, 273:1516-7.
14. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001, 29:306-9.
15. Barrett JC, Clayton DG, Concannon P. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009, 41:703-707.
16. Cooper JD, Smyth DJ, Smiles AM. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet 2008, 40:1399-401.
17. Wallace C, Newhouse SJ, Braund P. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008, 82:139-49.
18. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003, 101:2089-93.
19. Tosetto A, Rodeghiero F, Castaman G. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006, 4:766-73.
20. Biss TT, Blanchette VS, Clark DS. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost 2010, 41:677-687.
21. Bowman M, Riddel J, Rand ML, Tosetto A, Silva M, James PD. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost 2009, 7:1418-21.
22. Soranzo N, Spector TD, Mangino M. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009, 41:1182-90.
23. Levy D, Ehret GB, Rice K. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009, 8:950-956.
24. Zhang ZP, Lindstedt M, Falk G. Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I. Am. J. Hum.Genet. 1992, 51:850-858.
25. Baronciani L, Cozzi C, Canciani MT. Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients. Blood Cells Mol.Dis. 2003, 30:264-270.
26. Schneppenheim R, Castaman G, Federici AB. A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3. J Thromb Haemost 2007, 5:722-728.
27. Ngo KY, Glotz VT, Koziol JA. Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease. Proc. Natl. Acad. Sci. U.S.A 1988, 85:2753-2757.
28. Shelton-Inloes SB, Chehab FE, Mannucci PM, Federici AB, Sadler JE. Gene deletions correlate with the development of alloantibodies in von Willebrand disease. J Clin Invest 1987, 79: